Discovery Structure Gene, mRNA, and precursor Clinical implications Receptors Regulation of synthesis and release Biological functions
ChemicalBook > CAS DataBase List > Somatostatin

Somatostatin

Discovery Structure Gene, mRNA, and precursor Clinical implications Receptors Regulation of synthesis and release Biological functions
Product Name
Somatostatin
CAS No.
51110-01-1
Chemical Name
Somatostatin
Synonyms
SRIF;GH-RIF;ay24910;panhibin;CCRIS 3629;Somatostain;Somatostatin;AGCKNFFWKTFTSC;SOMATOSTATIN-14;SOMATOSTATIN [GIF]
CBNumber
CB3417645
Molecular Formula
C76H104N18O19S2
Formula Weight
1637.88
MOL File
51110-01-1.mol
More
Less

Somatostatin Property

storage temp. 
−20°C
solubility 
H2O: 1 mg/mL
form 
powder
Water Solubility 
Soluble in water (0.3 mg/ml)
More
Less

Safety

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-36
WGK Germany 
3
RTECS 
WF8751700
3-10-21
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Tocris
Product number
1157
Product name
Somatostatin
Packaging
1
Price
$115
Updated
2021/12/16
Usbiological
Product number
S5331-20A
Product name
Somatostatin 14
Packaging
5mg
Price
$386
Updated
2021/12/16
TRC
Product number
S676753
Product name
Somatostatin
Packaging
5mg
Price
$110
Updated
2021/12/16
TRC
Product number
S676753
Product name
Somatostatin
Packaging
100mg
Price
$825
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
INB0001616
Product name
SOMATOSTATIN 14
Purity
95.00%
Packaging
0.1MG
Price
$764.5
Updated
2021/12/16
More
Less

Somatostatin Chemical Properties,Usage,Production

Discovery

Somatostatin is a tetradecapeptide exerting a growth hormone (GH) release-inhibiting activity. SS also has a large variety of neuromodulatory and gastrointestinal actions, mostly as an inhibitory hormone. SS of 14 aa residues (SS-14) was first isolated from ovine hypothalamic extracts by Roger Guillemin’s group in 1973 and was originally named GH inhibiting factor. An N-terminally extended form of 28 aa residues (SS-28) was isolated later from the porcine gut. SS cDNA that encodes a precursor for SS-14 and SS-28, a product of the SS1 gene (approved symbol SST), was first cloned from the anglerfish pancreas in 1980. In this report, another SS cDNA encoding a different precursor (formerly called SSII), a product of the SS3 gene, was also isolated. Subsequently, cDNAs and genes encoding SS precursors have been identified in many animals by molecular cloning and bioinformatic analyses, and so far six paralogous genes (SS1, SS2, SS3, SS4, SS5, and SS6) have been identified in vertebrates. Accordingly, two SS-related peptides, cortistatin (CST)5 and neuronostatin, have been identified.

Structure

SS-14 and SS-28 contain a disulfide bridge and have a cyclic structure. CST, a product of the SS2/CST gene, is 14–17 aa residues in length, depending on the species, and contains the SS2 signature, a proline residue at position 2. CST in placental mammals exhibits an additional lysine residue at its C-terminal extremity. Neuronostatin is a 13-residue amidated peptide that is flanked with the signal peptide of the SS1 precursor, and is an acyclic peptide.  The aa sequence of SS-14 is fully conserved in vertebrates. SS-28 in mammals that contains the SS-14 moiety at its C-terminal shares 40%–66% sequence identity with its counterparts in fish. Mr 1638 (SS-14), 3149 (SS-28). Soluble in water, acid, and methanol. Stable in solution at -80°C for more than a year. Plasma half-life is <3min.

Gene, mRNA, and precursor

The human preproSS gene (SS1), SST, location 3q28, consists of two exons. Mammalian SS-14 and SS-28 are derived from preproSS1 of 116 aa residues by specific proprotein convertases (PCs) through tissue-specific posttranslational processing. In vertebrates, six SS genes have been identified, and all these paralogs are present in teleost fish while only SS1 and SS2/CST are present in tetrapods. Phylogenetic and comparative genomic analyses showed that whole-genome duplications, local duplications, and gene losses contribute to the divergent evolution of SS genes.

Clinical implications

Somatostatinoma is a malignant tumor that arises from transformed D cells in the pancreatic islets or duodenum. Somatostatinomas are associated with malabsorption, diabetes mellitus, steatorrhea, and cholelithiasis. In gastroenteropancreatic tumors, high levels of SS receptor expression have been found, and specifically designed analogs are used for tumor imaging and radiotherapy. SS deficiency causes persistent Helicobacter pylori infection in the patient with chronic gastritis.

Receptors

SS receptors belong to the family of seventransmembrane-domain GPCRs. There are five subtypes (sst1–sst5), and all these receptors bind to SS and CST with high affinity.7 The structural and functional characteristics of these receptors in humans, including signal transduction pathways, agonists, and antagonists.

Regulation of synthesis and release

SS secretion in the gastrointestinal tract is regulated by the autonomous nervous system and various gut regulatory peptides including gastrin, cholecystokinin (CCK), and substance P. The synthesis and release of hypothalamic SS are regulated by GH, growth hormone-releasing hormone (GHRH), and glucose.

Biological functions

In the anterior pituitary, SS inhibits the release of GH and thyroid-stimulating hormone (TSH). Pulsatile GH secretion reflects the pulsatile release of both SS and GHRH in a reciprocal fashion. In fish, SS-14 inhibits the release of GH, prolactin, and insulin. In the brain, SS has a variety of neuromodulatory roles in learning, cognitive functions, locomotor activity, anxiety, and depression. CST has physiological functions, such as depression of neuronal activity and induction of slowwave sleep. Moreover, SS exerts inhibitory effects on various gastrointestinal functions, including gastric acid secretion, gastric emptying, intestinal motility, and release of insulin, glucagon, and various gastrointestinal hormones.

Description

Originally isolated from hypothalamic tissue, somatostatin is characterized as an inhibitor of growth hormone (GH) release. The structure was determined in 1971. Subsequent investigations led to the recognition that somatostatin also was released from the pancreas and has a role of inhibiting the secretion of both insulin and glucagon. A total of five somatostatin receptor subtypes have been characterized and cloned (sst1 to sst5). Subtype sst4 is associated with the inhibition of insulin release, and an sst4-selective inhibitor has been reported. The somatostatin analogue SOM230 has exhibited selectivity for sst1, sst2, sst3, and sst5 in rats and effectively decreased plasma GH and insulin-like growth factor-1 (IGF-1) levels by 75% without significant effects on insulin or glucagon. Another analogue, PT R3173, with selectivity for recombinant human somatostatin receptor (hsst2, hsst4, hsst5) was substantially more effective in inhibiting GH secretion compared to glucagon and insulin release in rats.

Uses

Somatostatin is a peptide hormone that regulates the endocrine system. Extensive SS analogs with improved pharmacokinetics, bioavailability, and receptor subtype selectivity have been developed. These include nonpeptidergic analogs and octapeptides such as octreotide and lanreotide. Octreotide and lanreotide are long-acting sst2-preferring agonists, and are used for the treatment of acromegaly, gastroenteropancreatic tumors, neuroendocrine tumors, and other gastrointestinal disorders such as secretory diarrhea and gastrointestinal bleeding.

Indications

Somatostatin (or somatotropin release–inhibiting factor [SRIF]) occurs primarily as a 14–amino acid peptide, although a 28–amino acid form also exists.As with the other hypothalamic peptides, it is formed by proteolytic cleavage of a larger precursor. Somatostatin, originally isolated from the hypothalamus, is also in many other locations, including the cerebral cortex, brainstem, spinal cord, gut, urinary system, and skin. Somatostatin inhibits the secretion of many substances in addition to growth hormone.

General Description

Somatostatin was discovered in the hypothalamus. It is elaboratedby the δ-cells of the pancreas and elsewhere in thebody. Somatostatin is an oligopeptide (14 amino acidresidues) and is referred to as somatotropin release–inhibitingfactor (SRIF).
Its primary action is inhibiting the release of GH from thepituitary gland. Somatostatin also suppresses the release ofboth insulin and glucagon. It causes a decrease in bothcAMP levels and adenylate cyclase activity. It also inhibitscalcium ion influx into the pituitary cells and suppressesglucose-induced pancreatic insulin secretion by activatingand deactivating potassium ion and calcium ion permeability,respectively. The chemistry, SARs, and potential clinicalapplications have been reviewed.

Mechanism of action

Somatostatin binds to 6 somatostatin receptor (SSTR) subtypes, which are G protein-coupled receptors (GPCRs) that inhibit adenylate cyclase after activation. It then inhibits intracellular cyclic adenosine monophosphate and Ca2+, while increasing outward potassium currents, ultimately reducing target tissue hormone secretion. Somatostatin can also achieve anti-tumor effects through anti-proliferation and cell inhibition.

Clinical Use

Somatostatin has a very brief half-life in serum and is not useful clinically.An 8–amino acid analogue with 2 D-amino acids substituted for the naturally occurring L-amino acids is more stable, and monthly injections of a depot form of this analogue (octreotide, Sandostatin LAR) have several uses. Long-acting octreotide is used to treat acromegaly, as described earlier. It is also used to counteract unpleasant effects caused by overproduction of secreted bioactive substances produced by neuroendocrine tumors, including hyperinsulinemia from insulinomas and secretions from carcinoid tumors that cause severe diarrhea. Octreotide may also control severe diarrhea associated with AIDS that has not responded to other treatments.

Side effects

Somatostatin analogues (SSA) are a common treatment for some forms of neuroendocrine tumours (NETs). Somatostatin analogues are usually well tolerated which means you may not have many side effects.
The main side effects are
Loss of appetite
Feeling sick
Feeling bloated
Stomach pain
Fatigue (tiredness)
Increased diarrhoea (this is rare)
Soreness at the injection site
Uncommon side effects include sinus bradycardia, asthenia, headache,pruritus, decreased libido, increased serum bilirubin, and constipation.
Transient side effects, gastrointestinal discomfort and decreased glucose tolerance, usually last only a few weeks after initiation of therapy.
The most significant side effect associated with prolonged use of octreotide is formation of gallstones resulting from reduced bile flow.

storage

-20°C

Somatostatin Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Somatostatin Suppliers

Kunming jida pharmaceutical co. LTD
Tel
0871-68356968 13000000000
Fax
86-0871-6835699
Email
jidamd@jida.com.cn
Country
China
ProdList
12
Advantage
58
Hangzhou Peptidego Biotech Co.,Ltd.
Tel
0571-87213919
Email
Eric@peptidego.com
Country
China
ProdList
7408
Advantage
58
Harbin Jixianglong Biotech Co., Ltd.
Tel
18246018015
Email
1348764518@qq.com
Country
China
ProdList
22
Advantage
58
Shanghai Fine Biotech Co.,Ltd
Tel
18221172427
Email
sale@fine-biotech.com
Country
China
ProdList
2746
Advantage
58
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Fax
86-21-50328109
Email
3bsc@sina.com
Country
China
ProdList
15838
Advantage
69
Alabiochem Tech.Co., Ltd.
Tel
512-58900862 400-0707518
Fax
0086-512-56765862
Email
sales@alabiochem.com
Country
China
ProdList
970
Advantage
59
GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Fax
86-21-61263399
Email
ymbetter@glbiochem.com
Country
China
ProdList
9981
Advantage
64
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
15402
Advantage
60
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Fax
010-65763397
Email
waley188@sohu.com
Country
China
ProdList
12335
Advantage
58
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3239
Advantage
55
TargetMol Chemicals Inc.
Tel
021-021-33632979 15002134094
Fax
021-33632979
Email
marketing@targetmol.com
Country
China
ProdList
7783
Advantage
58
Hubei XinyuanShun Chemical Co., Ltd.
Tel
13971561712, 13995564702, 027-50664929
Fax
027-50664927
Email
hbeixys2001@163.com
Country
China
ProdList
3120
Advantage
55
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Fax
051085625359
Email
sales@reading-chemicals.com
Country
China
ProdList
15178
Advantage
58
Finetech Industry Limited
Tel
027-87465837 19945049750
Fax
027-8777-2287
Email
sales@finetechnology-ind.com
Country
China
ProdList
9637
Advantage
58
Shanghai Macklin Biochemical Co.,Ltd.
Tel
15221275939
Fax
021-50706099
Email
shenlinxing@macklin.cn
Country
China
ProdList
15873
Advantage
55
Shanghai HuanChuan Industry Co.,Ltd.
Tel
021-61478794
Fax
021-61478794
Email
sales@hcshhai.com
Country
China
ProdList
9793
Advantage
50
AdooQ Bioscience CHINA
Tel
025-58849295 18951903616;
Fax
025-68650336
Email
info@adooq.cn
Country
China
ProdList
2990
Advantage
60
BEIJING EAGLE SKY PHARMATECH CO., LTD
Tel
010-88755821 13911359480
Email
sophia_818@126.com
Country
China
ProdList
294
Advantage
55
Hangzhou Peptide Biochem Co.,Ltd
Tel
0571-89197072; 18668118770
Fax
0571-89197072
Email
linda@peptide-china.com
Country
China
ProdList
235
Advantage
56
Shanghai Send Pharmaceutical Technology Co., Ltd.
Tel
021-58088081 Q2635253576
Fax
QQ3382968513
Email
hailey@shsendpharm.com
Country
China
ProdList
1984
Advantage
55
Jinan Putubio Tech Co., Ltd.
Tel
+86 (531) 8099-2215
Fax
+86 (531) 8099-2215
Email
putubio@outlook.com
Country
China
ProdList
1261
Advantage
55
Shanghai Haozhixiang Biotechnology Co., Ltd
Tel
526763801 13301653310
Fax
+86-21-51619052
Email
526763801@qq.com
Country
China
ProdList
9288
Advantage
55
Avantpbc Chemical Tech(Shanghai) Co,Ltd.
Tel
17802107445
Country
China
ProdList
185
Advantage
55
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
Raw material medicin reagent co.,Ltd
Tel
Email
sales@njromanme.com
Country
China
ProdList
4529
Advantage
58
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Fax
21-5161 9052
Email
Sales@ATKchemical.com
Country
China
ProdList
9125
Advantage
58
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 18892239720
Fax
010-60605840
Email
psaitong@jm-bio.com
Country
China
ProdList
12306
Advantage
58
Nanjing Peptide Biotech Ltd.
Tel
025-58361106-805 15951641583
Fax
025-58361106-806
Email
zhao.xu@njpeptide.com
Country
China
ProdList
9979
Advantage
55
Chengdu Youngshe Chemical Co., Ltd.
Tel
+86-17380623303
Fax
028-62328193
Email
Caroline@youngshechem.com
Country
China
ProdList
4802
Advantage
58
Shenzhen Regent Biochemical Technology Co., Ltd.
Tel
0755-85201366 18938635012
Fax
0755-85201366
Email
sales@regentsciences.com
Country
China
ProdList
9750
Advantage
58
Hubei Xinyuanshun Pharmaceutical Chemical Co., Ltd.
Tel
027-51831887 15337167856
Fax
027-51837635 QQ1165326703
Email
hubeixinyuanshun@163.com
Country
China
ProdList
10295
Advantage
58
Nanjing crow LuNing pharmaceutical technology co., LTD
Tel
13382066392
Country
CHINA
ProdList
4877
Advantage
58
Hubei Dibai Chemical Co., Ltd.
Tel
027-87058617 15872383390
Fax
027-87058617
Email
hbdibo@163.com
Country
China
ProdList
856
Advantage
58
Beijing Minruida Technology Co., Ltd.
Tel
010-82387566 18001021521;
Fax
82387566-801
Email
sales@mreda.com.cn
Country
China
ProdList
10083
Advantage
58
Guangzhou Belka Biological Technology Co., Ltd.
Tel
+86-18665676617
Fax
18665676617
Country
China
ProdList
957
Advantage
58
Chengdu MassCale Pharmaceutical Co., Ltd.
Tel
028-84552636 18084815636
Email
chensfsc@126.com
Country
China
ProdList
1445
Advantage
58
Finetech Industry Limited
Tel
+86-27-8746-5837 +8619945049750
Fax
86 27 87772287
Email
info@finetechnology-ind.com
Country
China
ProdList
9629
Advantage
58
Hebei Yanxi Chemical Co., Ltd.
Tel
+8618531123677
Email
faithe@yan-xi.com
Country
China
ProdList
5853
Advantage
58
Zhejiang J&C Biological Technology Co.,Limited
Tel
+1-2135480471
Email
sales@sarms4muscle.com
Country
China
ProdList
10473
Advantage
58
Wuhan Fortuna Chemical Co., Ltd
Tel
+86-027-59207850 +86-13986145403;
Fax
86-27-59524646
Email
info@fortunachem.com
Country
China
ProdList
5992
Advantage
58
Hefei TNJ Chemical Industry Co.,Ltd.
Tel
+86-0551-65418671 +8618949823763
Fax
0551-65418697
Email
sales@tnjchem.com
Country
China
ProdList
34563
Advantage
58
Hangzhou Go Top Peptide Biotech
Tel
0571-88211921
Email
sales1@gotopbio.com
Country
CHINA
ProdList
2609
Advantage
58
Baoji Guokang Healthchem co.,ltd
Tel
+8615604608665 15604608665
Email
dominicguo@gk-bio.com
Country
CHINA
ProdList
9414
Advantage
58
Baoji Guokang Healthchem Co., Ltd.
Tel
+86-0917-3909592 +86-13892490616
Fax
09173909592
Email
gksales1@gk-bio.com
Country
China
ProdList
9209
Advantage
58
Shaanxi Dideu Medichem Co. Ltd
Tel
+86-029-89586680 +86-18192503167
Fax
+86-29-88380327
Email
1026@dideu.com
Country
China
ProdList
8025
Advantage
58
SIMAGCHEM CORP
Tel
+86-5922680277 +86-13806087780
Email
sale@simagchem.com
Country
China
ProdList
17346
Advantage
58
Chemwill Asia Co.,Ltd.
Tel
86-21-51086038
Fax
86-21-51861608
Email
chemwill_asia@126.com
Country
CHINA
ProdList
23912
Advantage
58
Shanghai TenSus Biotechnology Co., Ltd.
Tel
021-50895067 18616507272
Fax
021-50895067
Email
tensus@163.com
Country
China
ProdList
8073
Advantage
58
Cangzhou Wanyou New Material Technology Co.,Ltd
Tel
18631714998
Email
sales@czwytech.com
Country
CHINA
ProdList
904
Advantage
58
Zhengzhou Edward Biology Co.,Ltd
Tel
0371-63682289 15538176268
Fax
QQ:1875164801
Email
jacschem@163.com
Country
China
ProdList
9926
Advantage
58
More
Less

View Lastest Price from Somatostatin manufacturers

Hainan Fubai Trading Co., LTD
Product
Somatostatin 51110-01-1
Price
US $1.00/g
Min. Order
10g
Purity
99
Supply Ability
999
Release date
2025-09-22
Chengdu Shengnuo Biopharm Co.,Ltd
Product
Somatostatin Acetate 51110-01-1
Price
US $1000.00-1000.00/g
Min. Order
1g
Purity
>=99% (HPLC), USP43
Supply Ability
10000000g
Release date
2025-09-19
Xi an Biohorlden Industry Trade Co Ltd
Product
Somatostatin Acetate 51110-01-1
Price
US $0.00-0.00/g
Min. Order
1g
Purity
99%
Supply Ability
200g
Release date
2025-06-13

51110-01-1, SomatostatinRelated Search:


  • panhibin
  • M.W. 1637.80 C76H104N18O19S2
  • CCRIS 3629
  • Somatostatin
  • Anti-Somatostatin, N-Terminal antibody produced in rabbit
  • SOMATOSTATIN [GIF]
  • SOMATOSTATIN (HUMAN, OVINE, PORCINE, RAT, MOUSE)
  • SOMATOSTATIN (HUMAN, OVINE, PORCINE, RAT, MOUSE) 2ACOH 6H2O
  • SOMATOTROPIN RELEASE INHIBITING FACTOR
  • SOMATOTROPIN RELEASE INHIBITING FACTOR (HUMAN, OVINE, PORCINE, RAT, MOUSE)
  • SOMATOTROPIN RELEASE INHIBITING FACTOR (HUMAN, OVINE, PORCINE, RAT, MOUSE) 2ACOH 6H2O
  • SOMATOSTATIN, SHEEP
  • SOMATOSTATIN [TYR1]
  • 19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-(2-aminopropanoylamino)acetyl]amino]-13,25,28-tribenzyl-10,16-bis(1-hydroxyethyl)-7-(hydroxymethyl)-22-(1~{H}-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid
  • SOMATOSTATIN-14 (COUPLED TO BSA)
  • SOMATOSTATIN-14 (COUPLED TO KLH)
  • SOMATOSTATIN-14 (REDUCED)
  • SOMATOSTATIN [D-TRP8]
  • SOMATOSTATIN-14
  • SOMATOSTATIN ACETATE
  • SOMATOSTATIN, CYCLIC
  • SRIF (HUMAN, OVINE, PORCINE, RAT, MOUSE)
  • SRIF (HUMAN, OVINE, PORCINE, RAT, MOUSE) 2ACOH 6H2O
  • SRIF
  • GROWTH HORMONE RELEASE INHIBITING FACTOR
  • GROWTH HORMONE RELEASE INHIBITING FACTOR (HUMAN, OVINE, PORCINE, RAT, MOUSE)
  • GROWTH HORMONE RELEASE INHIBITING FACTOR (HUMAN, OVINE, PORCINE, RAT, MOUSE) 2ACOH 6H2O
  • GH-RIF
  • GIF (HUMAN, OVINE, PORCINE, RAT, MOUSE)
  • GIF (HUMAN, OVINE, PORCINE, RAT, MOUSE) 2ACOH 6H2O
  • H-ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS-OH
  • H-ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS-OH (COUPLED TO BSA)
  • H-ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS-OH (COUPLED TO KLH)
  • H-ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS-OH, CYS3,14, CYCLIC
  • H-ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS-OH (DISULFIDE BRIDGE: 3-14)
  • AGCKNFFWKTFTSC
  • AGCKNFFWKTFTSC (DISULFIDE BRIDGE: 3-14)
  • ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-PHE-THR-SER-CYS-OH
  • ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS
  • ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS 2ACOH 6H2O
  • ay24910
  • Somatostatin USP/EP/BP
  • Somatostatin Acetate(net)
  • Somatostatin panhibin
  • Somatostatin, Endogenous neuropeptide
  • Somatostain
  • 51110-01-1
  • 8916-34-6
  • Amino Acids and Peptides
  • BioChemical
  • Biochemicals and Reagents
  • Somatostatins
  • Peptides
  • Peptide
  • Somatostatin receptor